Enterprise Together with KSC
CVBIO Co., Ltd.
Israel
Company Overview
Business field: Development, manufacture, sales, and service of medical materials for intervention procedures
Goals for Growth: Develop technology-leading medical devices to improve the quality of life of patients based on basic technology in the field of interventional medical devices, and based on this, continue to expand the global market share and leap to a global medical device company
Sectors
- Medical and Health IT
Project Summary
- ① PTCA,PTA Vascular Balloon Catheter
- ② Coronary and Peripheral Stent System
- ③ Micro Medical Robot System for Vascular Disease
Business Model
- Revenue model Product sales
- Key Customer General Hospitals and agents
Major Performance
-
Sales
- USD 1.24M (2018)
- USD 1.23M (2019)
-
Investment
- USD 84,232 (Bluepoint Partners)
-
Employees
- (2018) 8
- (2019) 9
- (2020) 23
-
Patent
- Patent registrations: 10
Overseas Expansion
Stage
Preparing for overseas expansion
Status
Local approval in progress after sales of products for local approval in Uzbekistan.
Products / Services
1
6
- Target Country
- Israel
- Date of Establishment
- Apr. 12, 2011
-
- bruce626@naver.com bruce626@naver.com
-
- Location
- Dunchon-daero 457beon-gil, Jungwon-gu, Seongnam-si, Kyeonggi-do, Korea
-
- CEO
- Youngtae Lee
-
- Founder’s Background
-
- CVBIO Co., Ltd. CEO (2012~)
- Ostem Cardiotec Co., Ltd., Team Leader of R&D (2004-2011)
- Konkuk University, M.S. in Industrial Engineering